Form 4: Incyte EVP Sells Shares for Tax Obligations
Insider Transaction
Incyte Corp's EVP & Chief Medical Officer, Steven H. Stein, disposed of 13,292 shares of common stock to cover tax withholding obligations.
Summary
- Steven H. Stein, Executive Vice President and Chief Medical Officer of Incyte Corp (INCY), reported a transaction involving the company's common stock.
- On December 31, 2025, Mr. Stein disposed of 13,292 shares of Incyte common stock at a price of $98.77 per share.
- This disposition represents shares automatically withheld by Incyte to satisfy tax withholding obligations due at the settlement of previously reported Restricted Stock Units (RSUs) or earned performance shares.
- Following this transaction, Mr. Stein beneficially owns 49,837 shares of Incyte common stock directly.
- The total beneficial ownership includes an aggregate of 34,203 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not yet vested.
Sentiment
Score: 5
Explanation: The filing reports a routine, non-discretionary insider transaction for tax withholding purposes, which is neutral in sentiment and does not indicate any positive or negative operational or financial developments for the company.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
This Form 4 filing details a routine insider transaction for tax purposes, which is a common occurrence across all industries when executive compensation includes equity awards like Restricted Stock Units (RSUs) or performance shares. It does not provide insights into broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in management's discretionary view of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of earliest transaction, involving the disposition of common stock for tax withholding. |
| 01/05/2026 | Date the Form 4 was signed by the attorney-in-fact for Steven H. Stein. |
Keywords
Incyte Corp, INCY, Steven H. Stein, EVP & Chief Medical Officer, Insider Transaction, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Performance Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.